Published in Drug Week, September 21st, 2007
Direct comparisons of ofatumumab and rituximab revealed ofatumumab to induce much more rapid and profound CDC and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.